# Rothblatt Martine a: insider transactions

SEC CIK 1106578. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-29.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Chairperson & CEO, Director, Officer | 60 | 2026-10-21 | 2026-10-28 |

## Transactions: 60

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M), derivative | 9,500 | $0.00 | $0 | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 80 | $588.3913 | $47.1k | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 986 | $587.2653 | $579.0k | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 3,086 | $586.3694 | $1.8m | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,902 | $585.3585 | $1.1m | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 2,625 | $584.4314 | $1.5m | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 821 | $583.5017 | $479.1k | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-28 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M) | 9,500 | $117.76 | $1.1m | [Form 4](/filings/0001106578-26-000174.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M), derivative | 9,500 | $0.00 | $0 | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 80 | $592.835 | $47.4k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 600 | $592.054 | $355.2k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 700 | $590.9877 | $413.7k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,003 | $589.9833 | $591.8k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,597 | $588.9463 | $940.5k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,320 | $587.8821 | $776.0k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,417 | $586.9254 | $831.7k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 470 | $585.7166 | $275.3k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,417 | $584.8289 | $828.7k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 807 | $583.9443 | $471.2k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 89 | $582.6649 | $51.9k | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-27 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M) | 9,500 | $117.76 | $1.1m | [Form 4](/filings/0001106578-26-000173.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M), derivative | 9,500 | $0.00 | $0 | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 806 | $592.9168 | $477.9k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 694 | $591.60 | $410.6k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 680 | $590.5669 | $401.6k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,280 | $589.6378 | $754.7k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,241 | $588.4653 | $730.3k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 2,707 | $587.5413 | $1.6m | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,492 | $586.5445 | $875.1k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 600 | $585.7122 | $351.4k | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-26 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M) | 9,500 | $117.76 | $1.1m | [Form 4](/filings/0001106578-26-000172.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M), derivative | 9,500 | $0.00 | $0 | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 740 | $587.9997 | $435.1k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 542 | $586.9274 | $318.1k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 778 | $585.9914 | $455.9k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 676 | $584.7723 | $395.3k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 427 | $583.8348 | $249.3k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,732 | $582.7756 | $1.0m | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,650 | $581.8218 | $960.0k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,017 | $580.7801 | $590.7k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,038 | $579.7431 | $601.8k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 700 | $578.8004 | $405.2k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 200 | $577.6774 | $115.5k | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-23 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M) | 9,500 | $117.76 | $1.1m | [Form 4](/filings/0001106578-26-000171.md) |
| 2026-10-21 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Option exercise (M), derivative | 9,500 | $0.00 | $0 | [Form 4](/filings/0001106578-26-000169.md) |
| 2026-10-21 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 80 | $566.43 | $45.3k | [Form 4](/filings/0001106578-26-000169.md) |
| 2026-10-21 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 480 | $565.355 | $271.4k | [Form 4](/filings/0001106578-26-000169.md) |
| 2026-10-21 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 768 | $564.6309 | $433.6k | [Form 4](/filings/0001106578-26-000169.md) |
| 2026-10-21 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 1,253 | $563.4252 | $706.0k | [Form 4](/filings/0001106578-26-000169.md) |
| 2026-10-21 | [UNITED THERAPEUTICS Corp](/companies/uthr.md) | Sale (S) | 960 | $562.5403 | $540.0k | [Form 4](/filings/0001106578-26-000169.md) |

Page 1 of 2. [Older](/insiders/1106578.md?page=2)
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 00:00 ET. No prices; not investment advice.